Rhosean Scott is an associate in the firm’s New York office and focuses primarily on shareholder class actions involving mergers and acquisitions. She investigates corporate transactions, conflicted board actions, and disclosure deficiencies to help protect investor rights and maximize shareholder value.

Prior to joining KSF, Ms. Scott built a strong foundation at New York litigation boutiques representing plaintiffs in complex securities class actions.  She has extensive experience investigating and conducting discovery in securities fraud and antitrust matters on behalf of individual and institutional investors. As a member of the KSF team, Ms. Scott has contributed to significant recoveries in shareholder actions, including In re Aimmune Therapeutics, Inc. Securities Litigation ($27.5 million settlement) and Pearlstein v. BlackBerry Ltd. ($165 million settlement). Currently, she helps advance discovery across the firm’s ongoing merger and derivative matters.

Ms. Scott is a graduate of Tulane University Law School, and served as a judicial law clerk to the Hon. Charles R. Jones of the Louisiana Fourth Circuit Court of Appeal. She received a B.A. in Economics from Emory University.